2025 Guidelines for the Evaluation and Management of Adults With Congenital Heart Disease
December 19, 2025
Brand Name :
Resinol, R A Acne,
Synonyms :
resorcinol
Class :
Topical antipsoriatics
Dosage Forms & Strengths
Lotion
2%
3%
Lotion
Topical
Apply the required amount topically over the affected area, not exceeding three to four times a day
Dosage Forms & Strengths
Lotion
2%
3%
Lotion
Topical
For children of age 2 years and above:
Apply the required amount topically over the affected area, not exceeding three to four times a day
Refer to adult dosing
it may diminish the excretion rate when combined with gadofosveset, resulting in an enhanced serum level
applying resorcinol with adapalene topical on the same area may lead to excessive drying and irritation of the skin
applying resorcinol with alitretinoin topical on the same area may lead to excessive drying and irritation of the skin
applying resorcinol with bexarotene topical on the same area may lead to excessive drying and irritation of the skin
applying resorcinol with clascoterone topical on the same area may lead to excessive drying, irritation of the skin, scaling, or redness
applying resorcinol with tazarotene topical on the same area may lead to excessive drying and irritation of the skin
applying resorcinol with tretinoin topical on the same area may lead to excessive drying and irritation of the skin
applying resorcinol with trifarotene topical on the same area may lead to excessive drying and irritation of the skin
Actions and spectrum:
Resorcinol’s tendency for protein precipitation is the reason behind the agent’s efficaciousness in treating a range of topical dermatological conditions through the stimulation of antibacterial and keratolytic actions.
Frequency not defined
Difficulty breathing
Swelling of tongue, lips, face, or throat
Blue-colored skin
Seizure
Irregular heartbeat
Shallow breathing
Headache
Seizure
Black Box Warning
Not available
Contraindication/Caution:
Contraindication:
Hypersensitivity
Pregnancy consideration:
USFDA pregnancy category: not recommended
Lactation:
Data about the excretion of drugs into breast milk is not available
Pregnancy category:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus `in either the first or second trimester.
Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacodynamics:
Resorcinol is known to inhibit peroxidases present in the thyroid, further blocks thyroid hormone synthesis, and causes goiter
Pharmacokinetics:
Absorption
The rate of absorption, when applied topically, is very low. Absorption is lower when applied on the scalp than on the skin
Distribution
It is lipid-soluble
Metabolism
Limited data available
Elimination and excretion
Though limited information is available, the drug is known to be excreted in urine as a glucuronide metabolite.
Half-life:
14 hours
Administration:
Topical use only. Do not apply more than four times a day.
Patient information leaflet
Generic Name: resorcinol
Why do we use resorcinol?
Resorcinol is used to relieve burns, insect bites, sunburn, itching, and pain caused by scrapes and minor cuts etc. It is also used to treat psoriasis, eczema, acne, seborrhea, corns, warts etc.